Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers

VA Jespers; JM Van Roey; GI Beets; AM Buvé

doi:10.1097/QUA.0b013e31802bb35f

Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers

VA Jespers, JM Van Roey, GI Beets, AM Buvé

Research output: Contribution to journal › A1: Web of Science-article › peer-review

Original language	English
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	44
Issue number	2
Pages (from-to)	154-158
ISSN	1525-4135
DOIs	https://doi.org/10.1097/QUA.0b013e31802bb35f
Publication status	Published - 2007

Keywords

B780-tropical-medicine
Viral diseases
HIV
AIDS
Prevention strategies
Microbicides
Safety
Tolerability
Dosage
Clinical trials

Access to Document

10.1097/QUA.0b013e31802bb35f

http://lib.itg.be/pdf/itg/2007/2007jaid0154.pdf

Cite this

@article{65d78a02950a436d814d0e4ed26d2871,

title = "Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers",

keywords = "B780-tropical-medicine, Viral diseases, HIV, AIDS, Prevention strategies, Microbicides, Safety, Tolerability, Dosage, Clinical trials",

author = "VA Jespers and {Van Roey}, JM and GI Beets and AM Buv{\'e}",

note = "ITG-M1A; ITG-MLA; MICRO; U-HIVSTD; JIF; DOI; PDF",

year = "2007",

doi = "10.1097/QUA.0b013e31802bb35f",

language = "English",

volume = "44",

pages = "154--158",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

publisher = "Lippincott Williams & Wilkins",

number = "2",

}

TY - JOUR

T1 - Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers

AU - Jespers, VA

AU - Van Roey, JM

AU - Beets, GI

AU - Buvé, AM

N1 - ITG-M1A; ITG-MLA; MICRO; U-HIVSTD; JIF; DOI; PDF

PY - 2007

Y1 - 2007

KW - B780-tropical-medicine

KW - Viral diseases

KW - HIV

KW - AIDS

KW - Prevention strategies

KW - Microbicides

KW - Safety

KW - Tolerability

KW - Dosage

KW - Clinical trials

U2 - 10.1097/QUA.0b013e31802bb35f

DO - 10.1097/QUA.0b013e31802bb35f

M3 - A1: Web of Science-article

SN - 1525-4135

VL - 44

SP - 154

EP - 158

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

IS - 2

ER -